Conviction backed by things in hand: management stakes the next leg of growth on evidence it already possesses, not cond
The model's full reasoning — Q4 2017 call → NOWe need to determine if management expresses clear conviction about a step-up ahead and grounds it in concrete things already in hand or happening. Let's analyze the transcript. Management (Cliff Sifford and Kerry Jackson) discusses fiscal 2017 results and fiscal 2018 guidance. Key points: - They talk about strategic initiatives: CRM, Shoe Perks 2.0, vendor drop-ship, brand landing pages, etc. - They mention that they expect fiscal 2018 net sales to be in range of $1.13B to $1.23B with comparable store sales of low-single digits. Earnings per diluted share $1.85 to $2.00. - They talk about reducing store closures, improving margins, etc. But do they express clear conviction that the business is stepping up to a meaningfully higher level over the coming quarters? They give guidance, but is it a step-up? They had adjusted EPS of $1.49 in 2017, and they guide to $1.85-$2.00 for 2018, which is a significant increase. But is that a step-up in business level? They also mention that they expect to realize long-term operating income and EPS improvements from store closures. They talk about investments in CRM and technology. However, the question asks: "does management express CLEAR CONVICTION that the company's business is stepping up to a meaningfully higher level over the coming quarters, AND does it consistently ground that conviction in CONCRETE THINGS THE COMPANY ALREADY HAS IN HAND OR ALREADY HAPPENING — rather than in market conditions, industry recovery, or general optimism?" We need to see if management explicitly states that the business will be meaningfully bigger, busier, or stronger. They give guidance, but is that a step-up? They say "we expect fiscal 2018 net sales to be in the range of $1.13 billion to $1.23 billion" which is lower than 2017's $1.19 billion? Actually 2017 net sales were $1.19 billion. So the midpoint of 2018 guidance is $1.18 billion, which is slightly lower. But they also have store closures, so comparable store sales are expected to be up low single digits. So the business is not necessarily stepping up in total sales, but comps are up. However, EPS is expected to increase significantly due to tax reform and other factors. But is that a "step-up" in business level? The question is about the business being meaningfully bigger, busier, or stronger.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| INSM | Insmed Incorporated | Q4 2017 | 2018-02-23 | B |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| GPOR | Gulfport Energy Corporation | Q4 2016 | 2017-02-14 | A |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
CUE · Q3 2022 → YESThe question is: Does management express CLEAR CONVICTION that the company's business is stepping up to a meaningfully higher level over the coming quarters, AND does it consistently ground that convi...YES Management states clear conviction that the business is stepping up to a meaningfully higher level, citing the recent $30M PIPE financing, Fast Track designation, emerging clinical data from CUE-101 monotherapy and combination trials, and the derisked Immuno-STAT platform as concrete assets already in hand that support advancing toward 2024 clinical development and potential registration paths. They ground this in present-tense facts such as the SITC data, cash runway extension, first CUE-102 patient dosed, and ongoing trial expansions rather than external market or industry conditions.
BFIN · Q1 2022 → YESThe question is: Does management express CLEAR CONVICTION that the company's business is stepping up to a meaningfully higher level over the coming quarters, AND does it consistently ground that convi...YES Management states clear conviction that the business is stepping up: they have already achieved and exceeded the $40 million quarterly loan growth goal, are targeting $1.125–$1.150 billion in Q2 (with a reach to $1.2 billion by year-end), and expect EPS of $0. 14–$0.16 in Q2 rising $0.03–$0.05 per quarter thereafter, with ROE potentially in the 80s–90s run-rate by early 2023. This conviction rests on concrete, already-real evidence in hand: $45 million loan growth already booked in April 2022 (portfolio now over $1.
ALLY · Q1 2018 → YESThe question is: Does management express CLEAR CONVICTION that the company's business is stepping up to a meaningfully higher level over the coming quarters, AND does it consistently ground that convi...YES Management states clear conviction of a step-up: “we see these metrics meaningfully higher on a year-over-year basis, and that will fully continue over the medium term,” “adjusted EPS growth of 20% to 30% for the year,” “we expect net financing revenue to move higher,” “expect to see acceleration in this line item in Q2 and throughout the rest of 2018,” and “keeps us on the path to delivering our 2018 outlook.” That conviction is grounded in concrete, already-present items: record $9.